Category: Mid Day Movers

Shares of the NTRB stock skyrocketed in the current market trading session today on December 31, 2021. NTRB stock price saw a surge of 165.22% to reach $10.37 a share at the time of this writing. The stock was also green in the previous market trade and went up by 9.83% at closing. Let’s deep dive to understand the reason behind this rally.

What’s Happening?

NTRB stock soared after the company announced that the Korean Intellectual Property Office (KIPO) has completely issued its patent titled “Abuse and Misuse Deterrent Transdermal System”. This patent relates to the AVERSA™, which is the lead technology of the Nutriband. From the social media analysis, it seems that the investors are very happy with this news and anticipating the positive future of the NTRB stock. The positive sentiment led to the increase in the per-share price.

Nutriband Inc currently focusing on the development of transdermal pharmaceutical products. NTRB stock has a market cap of $59.85 million and a 1,427,303 average trading volume.

Previous News of NTRB stock

Couple of days ago, on December 29, 2021, Nutriband Inc did announce the share repurchase program in order to buy back $1,000,000 of common NTRB stock. The company had 7,773,962 outstanding shares of common stock as of December 29, 2021.

On December 21, 2021, the company announced the initiation of offering topical lotion contract manufacturing services. The company will offer the manufacturing of liquid-based topical, transdermal, and cosmetic products. The management of the company is striving hard to expand the manufacturing capabilities of the company in order to increase the revenue opportunities for the company. Considering such developments, it seems that NTRB stock will outperform in 2022.

NTRB Receives cGMP Certification:

On December 13, 2021, Nutriband did announce that Active Intelligence, a subsidiary of the company received the cGMP certification after the full cGMP audit. The audit was specifically related to certification of Pharmaceutical OTC GMP, 21 CFR Part 211/210. This is the key milestone of the company which will help in the growing contract manufacturing services of the company.

Wrap Up:

Things are going well for NTRB stock as far as market sentiment is concerned. The stock is ending the year 2021 with a great surge and can be a good bet for investors in the long run.

Shares of the Puxin Limited (NEW) stock were gloomy in the current market trading session today on December 30, 2021. NEW stock price saw a downtrend of 24.35% to drop at $0.40 a share at the time of this writing. The trading volume was 4,008,018, lower than the average trading volume on the last check. Let’s understand the current bearish sentiment of this stock.

What’s Happening?

NEW stock was bullish in the previous trading session after the company announced second-quarter 2021 financial results. It seems that the profit takers have stepped in after the previous surge due to which NEW stock became bearish today. Let’s have a look at recently announced second-quarter unaudited financial results.

Second Quarter 2021 Financial Results of NEW stock:

• According to the financial results, the company generated RMB674.1 million in revenue in the recently reported quarter. This represents an increase of 12.2% from RMB601.1 million in the same quarter of last year. The revenue for the first six months of the company was RMB1,360.9 million.
• The cost of revenues of the company was RMB376.2 million in the recently reported quarter. This represents an increase of 13.5% from the same period of the previous year.
• Gross profit of Puxin was RMB298.0 million in the second quarter of 2021, 10.5% higher than the same quarter of last year.
• Puxin Limited spent RMB1,660.0 million in operating expenses in the second quarter of 2021. These expenses significantly increased as compared to RMB299.6 million in the same tenure of the previous year.
• In the second quarter of 2021, the company suffered an operating loss of RMB1,362.0 million as compared to RMB29.9 million in the same quarter of last year. Operating loss for the first six months of 2021 was RMB1,355.5 million.
• Net loss attributable to NEW stock was RMB1,378.0 million as compared to RMB36.6 million net loss in the same tenure of the previous year.
• The adjusted net loss was RMB1,400.2 million in the second quarter of 2021. This compares to an adjusted net loss of RMB45.2 million in the same tenure of the previous year.
• Adjusted EBITDA in the recently reported quarter was RMB (1,368.3) million while this was RMB80.4 million in the same quarter of last year.

Wrap Up:

NEW stock declined today after getting positive momentum in the previous trade after the release of second-quarter 2021 financial results.  The per-share price in 2021 is not so much satisfactory as this stock lost 93% year to date.

Shares of the Future FinTech Group Inc. (FTFT) stock were rising in the current market today on December 30, 2021. FTFT stock price saw an uptrend of 19.67% to reach $1.47 a share at the time of this writing. The stock was gloomy in the previous trading session and went down by 12.77% at closing. Let’s understand the reason behind this bull.

What’s Happening?

Future FinTech Group recently announced that it has established a new blockchain division in order to manage the company’s existing blockchain business sector. This step will help the company in the formulation as well as execution of a strategic growth plan. Investors after hearing this news responded positively to the FTFT stock which led to the increase in per-share price in the current market.

Mr. Zhi Yan will serve as the President of the new division to direct the operations of the blockchain business of the company. The core purpose of the division is to develop, operate and manage the anticipated bitcoin mining farms in the United States and Paraguay. The company previously showed intentions about these farms. Moreover, the division will also coordinate Dubai-based digital currency trading service and crypto asset management business which the company previously announced, through FTFT Capital Investments LLC subsidiary.

FTFT appointed Mr. Kai Xu as the vice president of the new division. He will be responsible for optimizing blockchain computing hash power assets of the company and the development of Metaverse-related business.  Mr. Xu previously served as the manager of FT Commercial Group Ltd, a wholly-owned subsidiary of FTFT stock.

Previous News of FTFT stock

On Dec. 17, 2021, FTFT announced that it had entered into a cooperation agreement with APC Service Ltd. The purpose of this agreement is to build a cryptocurrency mining farm by establishing a joint venture in Ohio. In connection with the proposed mining farm, the first phase of the project will be 50MW of processing power. Upon success, the project size will be expanded to 300MW. The 50MW will deploy 12,000 S19 Antminers with  1.3 EH/s of hash power. Both parties have divided this project into six stages and estimated $10 million for each stage. The project upon successful completion will have a positive long-term effect on FTFT stock.

Conclusion

The recent announcement has made FTFT stock green in the premarket. It would be interesting to see how long this trend will persist as the stock market is highly unpredictable. The stock has lost almost 29% year to date.

Shares of the MingZhu Logistics Holdings Limited (YGMZ) stock were declining in the current market trading session today on December 29, 2021. YGMZ stock price saw a push of 5.68% to reach $1.86 a share at the time of this writing. The trading volume on the last check was 11,807,344, far higher than the average trading volume. Let’s deep dive to understand the reason behind this bull.

What’s Happening?

YGMZ stock became bullish today after the company announced the share purchase agreement for the acquisition of CheYi Network. MingZhu will acquire 100% equity of the equity interest of Cheyi (BVI) Limited under this agreement. The total consideration for this acquisition is an aggregate of $29,466,032. This consists of 3,189,000 fully paid ordinary shares of the YGMZ stock, $2,000,000 payment at closing, and Year-2021 and 2022 earnout payments of $8,826,019 and $5,884,013 respectively if the net income of the company to be acquired is no less than the $3,000,000 for the fiscal year 2021 and 2022. The transaction is expected to close by December 13, 2021.

CheYi Network is the comprehensive automobile service platform established in December 2015. It provides a variety of services to the automotive industry. Its integrated business platform consists of more than 6,000 vehicles and drivers.

Financial View of the YGMZ stock

In the previous month, the company announced unaudited financial results for the six months ended June 30, 2021, according to which

• MingZhu generated $9.6 million in revenue in the first six months of 2021. This represents an increase of $0.7 million, or 8.2% as compared to $8.9 million in the same period of the previous year. The subcontracting business of the company is mainly attributable to this increase.
• The gross profit of the YGMZ stock was $1.4 million in the first half of 2021. This represents an increase of $0.2 million, or 15.0% from $1.2 million gross profit in the same tenure of the previous year.
• The gross margin of the company was 14.3%, 0.8 percentage points higher than the gross margin in the same period of the previous year.
• The company spent $932,409 in general and administrative expenses in the first six months of 2021. These expenses were $579,139 in the same tenure as the previous year.
• The operating income of the YGMZ stock was $386,940 in the recently reported tenure, 24.0% higher than the same period of the previous year.
• The company ended the quarter with $14.2 million in cash, cash equivalents, and restricted cash.

Wrap Up

The momentum is positive for YGMZ stock after the announcement of the share purchase agreement by MingZhu. The per-share price declined by 15.12% in the last thirty days and almost 82% year to date.

Shares of the Kiniksa Pharmaceuticals, Ltd. (KNSA) stock were gloomy in the current market trading today on December 28, 2021. KNSA stock price saw a downtrend of 2.48% to reach $12.18 a share at the time of this writing. The trading volume was 706,241 on the last check. Let’s deep dive to explore more about this stock.

What’s Happening?

KNSA stock became bearish after the company announced the results from the Phase 3 Trial of Mavrilimumab in COVID-19-Related ARDS. According to the results, the mavrilimumab did not meet the primary efficacy endpoint. Mavrilimumab is an investigational fully human monoclonal antibody intended for the COVID-19-related acute respiratory syndrome. This antibody targets the granulocyte-macrophage colony that simulates factor receptor alpha.

The purpose of the Phase 2/3 trial was to evaluate the safety and efficacy of the mavrilimumab to treat hospitalized adult patients with hypoxia and severe COVID-19 pneumonia/hyperinflammation. 582 patients participated in the Phase 3 portion of the trial.

Financial View of the KNSA stock

At the beginning of November, Kiniksa announced third quarter 2021 financial results according to which

• The company generated $12.1 million in revenue from the sales of ARCALYST products in the third quarter of 2021.
• Net loss of KNSA stock was $30.5 million in the third quarter of 2021. Net loss in the same quarter of last year was $43.8 million.
• Kiniksa spent $42.8 million in operating expenses in the third quarter of 2021. The company reported operating expenses of $43.2 million in the same tenure of the previous year. Non-cash, share-based compensation expense in the recently reported quarter was  $6.2 million. Non-cash, share-based compensation expense for the third quarter of 2020 was $5.6 million.
• The company ended the quarter with $200.2 million in cash, cash equivalents, and short-term investments.

Financial Guidance of KNSA stock

Kiniksa Pharmaceuticals expects net revenue for the ARCALYST in the fourth quarter of 2021 in the range of $16.0 million to $17.0 million. The management of the company expects that the company has enough cash, cash equivalents, and short-term investments to finance the operations till 2023.

Wrap Up

Things are not going well for KNSA stock as far as market sentiment is concerned. The situation has become challenging for the management of the company after the phase 3 trial results of the Mavrilimumab. In a nutshell, investors need to do deep research before making any decision.

Shares of the Baudax Bio, Inc. (BXRX) stock were declining in the current market today on December 28, 2021. BXRX stock price saw a downtrend of 23.93% to drop at $0.24 a share at the time of this writing. The stock was also gloomy in the previous trade and went down by 0.02% at closing. Let’s deep dive to know the reason behind this decline.

What’s Happening?

BXRX stock further declined today after the announcement of a $4.2 million registered direct offering by Baudax Bio. The company announced that it has signed the definitive agreement with certain institutional investors for the issuance and offering of 42,289.3 shares of convertible preferred BXRX stock. Moreover, the company will issue warrants to buy up to an aggregate of 12,686,790 shares of BXRX common stock.

The company expects the gross proceeds of $4.2 million under this offering. The stated value is $100 per share for the shares of preferred stock. These shares will be converted to an aggregate of 16,915,720 shares of common stock after the closing date at a $0.25 per share conversion price. The exercise price for warrants is $0.32 per share and can be exercisable six months following the issuance date. The warrants will become expire after the five years of the initial exercise date. The offering will be closed on or about December 28, 2021, after meeting the customary closing conditions.

Financial View of BXRX stock

• In the third quarter of 2021, BXRX generated $0.3 million in net product revenue as compared to $0.1 million in the same tenure of the previous year.
• Cost of sales of the Baudax Bio was $0.5 million in the third quarter of 2021. Cost of sales remained unchanged as compared to the same quarter of last year.
• The company spent $0.7 million in research and development expenses in the third quarter of 2021. These expenses were $1.5 million in the same period of the previous year.
• Selling, general and administrative expenses of the company were $11.1 million in the recently reported quarter. These expenses were $13.8 million in the same tenure of the previous year.
• Net loss of the BXRX stock was $(0.20) per diluted share or $17.0 million in the three months ended September 30, 2021.
• The company ended the quarter with $24.9 million in cash, cash equivalents, and short-term investments.

Wrap Up

The announcement of public registered direct offering is the obvious reason for the decline in the per-share price of the BXRX stock. The year-to-date loss for this stock is 76.30%.

Shares of the Lizhi Inc. (LIZI) stock were declining in the current market today on December 27, 2021. LIZI stock price saw a decline of 2.0% to reach $1.71 a share at the time of this writing. The trading volume on the last check was 1,228,108, far higher than the average trading volume. Let’s deep dive to understand the reason behind this decline.

What’s Happening?

The company announced the In-car Audio partnership agreement with Luxury Smart Electric Vehicle Brand HiPhi. The company has already integrated its in-car audio products into the in-car entertainment systems of HiPhi vehicles. In the start of the current market the LIZI stock was bullish but then became bearish.

The management is delighted to partner with HiPhi as it is executing its strategy of a broad range of usage scenarios of its in-car products. This partnership will not only leverage the in-car entertainment experience for HiPhi vehicle owners but also increase the audience for LIZHI’s outstanding podcast content.

Recently LIZHI podcast introduced new functions such as voice search and voice control for in-car use. The company is putting great effort to enhance the interactive audio user experience of its audio products.

Financial View of LIZI stock:

On November 30, 2021, LIZI announced third quarter 2021 financial results according to which

• Net revenues increased by 40% to reach RMB504.8 million in the third quarter of 2021 as compared to the same quarter of last year.
• The company reported RMB353.6 million cost of the revenue in the recently reported quarter. These costs increased by 31% as compared to RMB270.9 million in the same quarter of last year.
• The gross profit of the LIZI stock was RMB151.3 million in the third quarter of 2021. The gross profit was RMB90.6 million in the same tenure as the previous year.
• The gross margin in the recently reported quarter was  30% while it was 25% in the third quarter of 2020. The non-GAAP gross margin was 31% in the third quarter of 2021.
• LIZI spent 3 million in operating expenses in the third quarter of 2021. This represents an increase of 91% in operating expenses from the same tenure of the previous year.
• LIZI stock suffered a net loss of RMB37.1 million in the third quarter of 2021, while this loss was  RMB6.1 million in the same quarter of last year.

Wrap Up:

LIZI stock declined despite the announcement of a partnership agreement by the company with HiPhi. The progress in 2021 was not satisfactory as LIZI stock lost almost 57% year to date.